[go: up one dir, main page]

WO2003004599A3 - Produits de recombinaison d'expression procaryotique, leurs procedes de production et d'utilisation dans l'expression de proteines de recombinaison dans des systemes d'expression procaryotique - Google Patents

Produits de recombinaison d'expression procaryotique, leurs procedes de production et d'utilisation dans l'expression de proteines de recombinaison dans des systemes d'expression procaryotique Download PDF

Info

Publication number
WO2003004599A3
WO2003004599A3 PCT/IL2002/000540 IL0200540W WO03004599A3 WO 2003004599 A3 WO2003004599 A3 WO 2003004599A3 IL 0200540 W IL0200540 W IL 0200540W WO 03004599 A3 WO03004599 A3 WO 03004599A3
Authority
WO
WIPO (PCT)
Prior art keywords
expression
fusion polypeptide
making
methods
recombinant proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2002/000540
Other languages
English (en)
Other versions
WO2003004599A2 (fr
Inventor
Yoav Peleg
Zeev Pancer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Biopharmaceuticals Ltd
Original Assignee
Insight Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Biopharmaceuticals Ltd filed Critical Insight Biopharmaceuticals Ltd
Priority to AU2002311620A priority Critical patent/AU2002311620A1/en
Publication of WO2003004599A2 publication Critical patent/WO2003004599A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003004599A3 publication Critical patent/WO2003004599A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé de production d'un polypeptide de fusion polypeptide dans des bactéries et sur son procédé de purification à partir des bactéries. Le procédé consiste à introduire dans les bactéries un produit de recombinaison d'expression codant le polypeptide de fusion qui comprend un peptide dérivé de TAT et une protéine d'intérêt. Le polypeptide dérivé de TAT sert au transport du polypeptide de fusion du cytoplasme bactérien au périplasme. Le polypeptide de fusion est ensuite purifié exclusivement à partir du périplasme bactérien.
PCT/IL2002/000540 2001-07-02 2002-07-02 Produits de recombinaison d'expression procaryotique, leurs procedes de production et d'utilisation dans l'expression de proteines de recombinaison dans des systemes d'expression procaryotique Ceased WO2003004599A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002311620A AU2002311620A1 (en) 2001-07-02 2002-07-02 Methods of making and using expression constructs for the expression of recombinant proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30180501P 2001-07-02 2001-07-02
US60/301,805 2001-07-02

Publications (2)

Publication Number Publication Date
WO2003004599A2 WO2003004599A2 (fr) 2003-01-16
WO2003004599A3 true WO2003004599A3 (fr) 2004-03-18

Family

ID=23164962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2002/000540 Ceased WO2003004599A2 (fr) 2001-07-02 2002-07-02 Produits de recombinaison d'expression procaryotique, leurs procedes de production et d'utilisation dans l'expression de proteines de recombinaison dans des systemes d'expression procaryotique

Country Status (2)

Country Link
AU (1) AU2002311620A1 (fr)
WO (1) WO2003004599A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102766645B (zh) * 2012-06-08 2013-06-05 武汉凯肽来生物科技有限公司 一种促进黄鳝生长的口服重组蛋白tat-gh及制备方法和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391457T3 (es) * 2003-08-13 2012-11-26 Sandoz Ag Procedimiento para la purificación de polipéptidos recombinantes
ATE353969T1 (de) 2003-08-13 2007-03-15 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
GB0319601D0 (en) * 2003-08-20 2003-09-24 Sandoz Ag Production process
WO2014084432A1 (fr) * 2012-11-30 2014-06-05 경상대학교 산학협력단 Vecteurs d'expression d'helicobacter pylori
CN111705032B (zh) * 2020-07-09 2022-04-05 科赫生物科技（北京）有限公司 一种原核表达细胞及其制备方法和应用
CN118562843B (zh) * 2024-08-05 2024-11-19 南京永正生物科技有限公司 一种高稳定性融合酶的制备方法及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221355B1 (en) * 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
US6485977B1 (en) * 1999-09-13 2002-11-26 Cornell Research Foundation, Inc. Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems
US20030018001A1 (en) * 1996-11-21 2003-01-23 Heaney Anthony P. Methods of using pituitary tumor transforming gene (PTTG) carboxy-terminal peptides to inhibit neoplastic cellular proliferation and/or transformation of breast and ovarian cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018001A1 (en) * 1996-11-21 2003-01-23 Heaney Anthony P. Methods of using pituitary tumor transforming gene (PTTG) carboxy-terminal peptides to inhibit neoplastic cellular proliferation and/or transformation of breast and ovarian cells
US6221355B1 (en) * 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
US6485977B1 (en) * 1999-09-13 2002-11-26 Cornell Research Foundation, Inc. Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102766645B (zh) * 2012-06-08 2013-06-05 武汉凯肽来生物科技有限公司 一种促进黄鳝生长的口服重组蛋白tat-gh及制备方法和应用

Also Published As

Publication number Publication date
AU2002311620A1 (en) 2003-01-21
WO2003004599A2 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
ATE299942T1 (de) Verfahren zur herstellung von natürlich gefalteten proteinen durch co-sekretion von molekularen chaperonen
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
CA2237296A1 (fr) Procede de preparation de peptides par l'intermediaire de proteines de fusion issues de la streptavidine
WO2005089093A3 (fr) Systemes d'expression ameliores a secretion du systeme sec
NO331271B1 (no) Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur, fremgangsmate, plasmid og vertscelle for fremstilling
WO2001029242A3 (fr) Modification post-traductionnelle de proteines de recombinaison produites dans les plantes
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
NO20090451L (no) Fremgangsmate for fremstilling av konjugater av insulin-lignende vekst faktor-1 og poly(etylenglukol)
WO2004113493A3 (fr) Compositions et procedes permettant l'expression accrue d'immunoglobulines a partir d'un seul vecteur utilisant un site de clivage peptidique
WO1997028247A3 (fr) PROTEINES DE RESERVE DE PLANTES ENRICHIES EN ACIDES AMINES, NOTAMMENT η-ZEINE DE MAIS ENRICHIE EN LYSINE, PLANTES EXPRIMANT CES PROTEINES
IL160338A0 (en) Method of protein production in plants
WO2001066778A3 (fr) Production de polypeptides etrangers dans des plantes sous forme d'hybrides de proteine de coque virales
NZ279002A (en) Production of recombinant human insulin by folding a proinsulin hybrid polypeptide obtained from a bacterial cell
EP1791961A4 (fr) Procede de production d'une proteine utilisant la proteine yebf
AU2003222717A1 (en) Streptavidin-binding peptide
WO2003004599A3 (fr) Produits de recombinaison d'expression procaryotique, leurs procedes de production et d'utilisation dans l'expression de proteines de recombinaison dans des systemes d'expression procaryotique
MXPA05012336A (es) Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales.
IL99079A0 (en) Protein structure of the plant toxin gelonin
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
NO971110L (no) Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
ES2264700T3 (es) Preparacion de una proteina recombinante en una celula huesped procariotica mediante el uso de un codon mejorado.
WO2003080660A3 (fr) Procede de preparation d'une proteine de liaison a l'heparine (hbp) mammifere recombinee
WO2005066208A3 (fr) Procede de production d'hormone de croissance de recombinaison sous forme de proteine hybride
AU2001240540A1 (en) Method for the manufacture of recombinant trypsin
WO2002055549A3 (fr) Systemes pour l'expression de proteines heterologues dans la bacterie m. capsulatus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP